Table 2.
Summary of fibromyalgia patient baseline questionnaire scores.
| Questionnaire | N | Mean (SD) | Median | Range |
|---|---|---|---|---|
| FIQ global | 2225 | 61.72 (14.73) | 61.9 | 8.8–99.1 |
| VASFIQ global | 2207 | 46.90 (10.63) | 47 | 5.2–70 |
| VASfatigue | 2216 | 7.86 (1.85) | 8.3 | 0.1–10 |
| VASsleep | 2215 | 7.81 (1.94) | 8.3 | 0.2–10 |
| VASanxiety | 2217 | 4.99 (2.94) | 5.2 | 0–10 |
| VASdepression | 2214 | 4.59 (2.98) | 4.7 | 0–10 |
| HADS-A | 2215 | 9.02 (4.42) | 9 | 0–21 |
| HADS-D | 2215 | 7.63 (4.20) | 7 | 0–21 |
| SPI | 2197 | 60.54 (17.75) | 61.4 | 4.5–100 |
| MAF-GFI | 2193 | 36.39 (7.95) | 37.8 | 7.5–50 |
FIQ, Fibromyalgia Impact Questionnaire; FM, fibromyalgia; HADS-A, Hospital Anxiety and Depression Scale—Anxiety sub-scale; HADS-D, Hospital Anxiety and Depression Scale—Depression subscale; MAF-GFI, Multidimensional Assessment of Fatigue — Global Fatigue Index; SD, standard deviation; SPI, Medical Outcomes Study Sleep Problems Index II; VAS, visual analog scale.